FDA places hold on Huntington's gene therapy trial

A clinical hold has been placed on Voyager's potential Huntington ’s disease drug, VY-HTT01.

Source: bizjournals.com Health Care:Physician Practices headlines - October 13, 2020 Category: American Health Authors: Allison DeAngelis Source Type: news